NWG vs. GSK
NWG (NatWest Group plc) and GSK (GSK plc) are both stocks. NWG operates in Banks - Diversified (Financial Services), while GSK operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, NWG returned 21.20%/yr vs 3.87%/yr for GSK. Their 0.30 correlation means their historical movements had little consistent relationship.
Performance
NWG vs. GSK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NWG achieves a 15.74% return, which is significantly higher than GSK's 6.85% return. Over the past 10 years, NWG has outperformed GSK with an annualized return of 21.20%, while GSK has yielded a comparatively lower 3.87% annualized return.
NWG
- 1D
- 2.53%
- 1M
- 7.95%
- 6M
- 7.62%
- YTD
- 15.74%
- 1Y
- 50.12%
- 3Y*
- 57.42%
- 5Y*
- 35.50%
- 10Y*
- 21.20%
- ALL TIME*
- -5.34%
GSK
- 1D
- -0.35%
- 1M
- -4.01%
- 6M
- -0.14%
- YTD
- 6.85%
- 1Y
- 42.28%
- 3Y*
- 19.02%
- 5Y*
- 4.56%
- 10Y*
- 3.87%
- ALL TIME*
- 8.46%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
GSK GSK plc | $273.47M | $239.22M | $208.37M |
| $84.71M | $74.61M | $77.84M |
NWG vs. GSK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NWG NatWest Group plc | 15.74% | 81.29% | 92.31% | -4.69% | 11.23% | 39.24% | -24.92% | 29.18% | -26.25% | 38.16% |
GSK GSK plc | 6.85% | 51.23% | -5.14% | 9.71% | -33.41% | 26.74% | -17.72% | 29.24% | 13.79% | -2.97% |
Correlation
The correlation between NWG and GSK is 0.25, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.25 |
Correlation (3Y) Balances recent behavior with more history. | 0.21 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.25 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.22 |
Correlation (All Time) Calculated using the full available price history since Oct 18, 2007 | 0.30 |
Fundamentals
NWG:
$38.66B
GSK:
$103.20B
NWG:
£3.14
GSK:
£2.36
NWG:
4.59
GSK:
16.16
NWG:
0.17
GSK:
0.36
NWG:
0.96
GSK:
2.34
NWG:
0.75
GSK:
4.42
NWG:
£30.19B
GSK:
£33.25B
NWG:
£17.56B
GSK:
£24.35B
NWG:
£9.33B
GSK:
£10.68B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NWG vs. GSK — Risk / Return Rank
NWG
GSK
NWG vs. GSK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for NatWest Group plc (NWG) and GSK plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NWG | GSK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.02 | ||
| Sortino ratioReturn per unit of downside risk | -0.12 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.28 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 2.10 | 2.29 | -0.20 |
| Martin ratioReturn relative to average drawdown | 5.21 | 4.96 | +0.25 |
Loading charts...
Drawdowns
NWG vs. GSK - Drawdown Comparison
The maximum NWG drawdown since its inception was -96.96%, which is greater than GSK's maximum drawdown of -55.70%. Use the drawdown chart below to compare losses from any high point for NWG and GSK.
Loading charts...
Drawdown Indicators
| NWG | GSK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.96% | -55.70% | -41.26% |
Max Drawdown (1Y)Largest decline over 1 year | -24.03% | -18.53% | -5.50% |
Max Drawdown (3Y)Largest decline over 3 years | -28.62% | -28.46% | -0.16% |
Max Drawdown (5Y)Largest decline over 5 years | -40.56% | -50.10% | +9.54% |
Max Drawdown (10Y)Largest decline over 10 years | -67.34% | -50.10% | -17.24% |
Current DrawdownCurrent decline from peak | -65.15% | -14.35% | -50.80% |
Average DrawdownAverage peak-to-trough decline | -86.06% | -18.85% | -67.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.64% | 8.54% | +1.10% |
Volatility
NWG vs. GSK - Volatility Comparison
NatWest Group plc (NWG) has a higher volatility of 10.42% compared to GSK plc (GSK) at 7.38%. This indicates that NWG's price experiences larger fluctuations and is considered to be riskier than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NWG | GSK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.42% | 7.38% | +3.04% |
Volatility (6M)Calculated over the trailing 6-month period | 26.00% | 19.79% | +6.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.85% | 26.54% | +5.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.52% | 25.39% | +8.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.68% | 22.98% | +13.70% |
Dividends
NWG vs. GSK - Dividend Comparison
NWG's dividend yield for the trailing twelve months is around 4.51%, more than GSK's 3.48% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK GSK plc | 3.48% | 3.42% | 4.60% | 3.75% | 5.47% | 4.99% | 5.59% | 4.35% | 5.65% | 5.83% | 6.86% | 5.93% |
NWG NatWest Group plc | 4.51% | 3.69% | 4.36% | 9.42% | 11.57% | 2.74% | 4.59% | 9.75% | 0.91% | 0.00% | 0.00% | 0.00% |
Financials
NWG vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between NatWest Group plc and GSK plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NWG vs. GSK - Profitability Comparison
NWG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, NatWest Group plc reported a gross profit of 4.58B and revenue of 7.86B. Therefore, the gross margin over that period was 58.3%.
GSK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, GSK plc reported a gross profit of 6.34B and revenue of 8.45B. Therefore, the gross margin over that period was 75.1%.
NWG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, NatWest Group plc reported an operating income of 2.30B and revenue of 7.86B, resulting in an operating margin of 29.2%.
GSK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, GSK plc reported an operating income of 2.41B and revenue of 8.45B, resulting in an operating margin of 28.5%.
NWG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, NatWest Group plc reported a net income of 1.69B and revenue of 7.86B, resulting in a net margin of 21.5%.
GSK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, GSK plc reported a net income of 437.26M and revenue of 8.45B, resulting in a net margin of 5.2%.
Frequently Asked Questions
NWG and GSK have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NWG has higher volatility (10.42%) compared to GSK (7.38%). In terms of maximum drawdown, NWG dropped -96.96% vs GSK's -55.70%.
GSK currently has the higher Sharpe Ratio (1.60 vs 1.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NWG and GSK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer